Furthermore, a haplotype analysis confirmed that the presence of one copy of the variants GSTO1*A (rs4925), GSTO2*G (rs156697), and GSTO2*G (rs2297235) was associated with an increased risk of ccRCC. Here, GSTO2 is linked to nonpapillary renal cell carcinoma.